The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV
The Effects of Highly Active Antiretroviral Therapy (HAART) on the Recovery of Immune Function in HIV-Infected Children and Young Adults
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
A NA clinical study on HIV Infections, this trial is completed. The trial is conducted by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and has accumulated 6 data snapshots since 2000. Infectious disease trials contribute critical data for public health response and treatment development.
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Feb 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Alhambra, United States, Aurora, United States, Baltimore, United States, Birmingham, United States, Boston, United States, Chicago, United States, Fort Lauderdale, United States, Gainesville, United States, Long Beach, United States, Miami, United States and 12 more location s